In the BioHarmony Drug Report Database

"Preview" Icon

Lovastatin

Altoprev, Mevacor (lovastatin) is a small molecule pharmaceutical. Lovastatin was first approved as Altoprev on 1987-08-31. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. In addition, it is known to target nuclear receptor subfamily 1 group I member 2 and integrin alpha-L.

 

Trade Name

 

Altoprev, Mevacor
 

Common Name

 

lovastatin
 

ChEMBL ID

 

CHEMBL503
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Lovastatin structure rendering